Titan Medical (NASDAQ:TMDI – Get Rating) and IceCure Medical (NASDAQ:ICCM – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Valuation and Earnings

This table compares Titan Medical and IceCure Medical's revenue, earnings per share (EPS) and valuation.

IceCure Medical has lower revenue, but higher earnings than Titan Medical. Titan Medical is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

IceCure Medical has a consensus target price of $4.80, suggesting a potential upside of 293.44%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than Titan Medical.

Volatility & Risk

Titan Medical has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of -0.2, indicating that its share price is 120% less volatile than the S&P 500.

Institutional & Insider Ownership

3.6% of Titan Medical shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Titan Medical and IceCure Medical's net margins, return on equity and return on assets.

Summary

IceCure Medical beats Titan Medical on 8 of the 13 factors compared between the two stocks.

About Titan Medical

(Get Rating)

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

About IceCure Medical

(Get Rating)

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.